J. Naginton, P. G. Watson, T. J. Playfair, J. Mcgill, B. R. Jones et al., Amoebic infection of the eye, Lancet, vol.2, pp.1537-1577, 1974.

S. T. Awwad, W. M. Petroll, J. P. Mcculley, and H. D. Cavanagh, Updates in Acanthamoeba keratitis, Eye Contact Lens, vol.33, pp.1-8, 2007.

R. Siddiqui and N. Khan, Biology and pathogenesis of Acanthamoeba, Parasites & vectors vol, vol.5, issue.6, 2012.

, Castellani A: An amoeba found in culture of yeast: preliminary note, J Trop Med Hyg, p.160, 1930.

G. Visvesvara, Classification of Acanthamoeba, Reviews of Infectious Diseases, vol.13, pp.369-372, 1991.

M. Pussard and R. Pons, Morphologies de la paroi kystique et taxonomie du genre

. Acanthamoeba, Protozoa Amoebida]. Pro-tistologica, vol.13, pp.557-610, 1977.

D. R. Stothard, J. Hay, J. M. Schroeder-diedrich, D. V. Seal, and T. J. Byers, Fluorescent oligonucleotide probes for clinical and environ-mental detection of Acanthamoeba and the T4 18S rRNA gene sequence type, J Clin Microbiol, vol.37, pp.2687-93, 1999.

H. Behera and . Sekhar, Isolation and genotyping of Acanthamoeba spp. from Acanthamoeba meningitis/ meningoencephalitis (AME) patients in

. India, Parasites & vectors, vol.9, p.442, 2016.

F. Arnalich-montiel, Influence of Acanthamoeba genotype on clinical course and outcomes for patients with Acanthamoeba keratitis in Spain, Journal of clinical microbiology, vol.52, pp.1213-1219, 2014.

B. Bowers and E. D. Korn, Cytochemical identification of phosphatase activity in the contractile vacuole of Acanthamoeba castellanii, J Cell Biol, vol.59, pp.784-91, 1973.

D. G. Dearborn and E. D. Korn, Lipophophonoglycan of the plasma membrane of Acanthamoeba castellanii, fatty acid composition, J Biol Chem, vol.249, pp.3342-3348, 1974.

F. R. Smith and E. D. Korn, 7-Dehydrostigmasterol and ergosterol: the major sterol of an amoebae, J Lipid Res, vol.9, pp.405-413, 1968.

A. G. Ulsamer, P. L. Wright, M. G. Wetzel, and E. D. Korn, Plasma and phagosome membranes of Acanthamoeba castellanii, J Cell Biol, vol.51, pp.193-215, 1971.

T. D. Pollard, E. Shelton, R. R. Weihing, and E. D. Korn, Ultrastructural characterization of Factin isolated from Acanthamoeba castellanii and identification of cytoplasmic filaments as F-actin by reaction with rabbit heavy meromyosin, J Mol Biol, vol.50, pp.91-98, 1970.

T. M. Preston, H. Richard, and R. S. Wotton, Locomotion and feeding of Acanthamoeba at the water-air interface of ponds, FEMS Microbiol lett, vol.194, pp.143-150, 2001.

G. Burger, I. Plante, K. M. Lonergan, and M. W. Gray, The mitochondrial DNA of the amoeboid protozoon, Acanthamoeba castellanii: complete sequence, gene content and genome organization, J Mol Biol, vol.245, pp.522-559, 1995.

. Chelkha, a phylogenetic study of acanth polyphaga draft genome, 2018.

I. J. Anderson, R. F. Watkins, J. Samuelson, D. F. Spencer, W. H. Majoros et al., Gene discovery in the Acanthamoeba castellanii genome, Protist, vol.156, pp.203-217, 2005.

R. N. Band and S. Mohrlok, The cell cycle and induced amitosis in Acanthamoeba, J Protozool, vol.20, pp.654-661, 1973.

!. 1%!,

Y. Hirukawa, H. Nakato, S. Izumi, T. Tsuruhara, and S. Tomino, Structure and expression of a cyst specific protein of Acanthamoeba castellanii, Biochim Biophys Acta, vol.1398, pp.47-56, 1998.

J. Lorenzo-morales-naveed and A. Khan, An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment, Parasite, vol.22, p.5, 2015.

Y. W. Ibrahim, Factors affecting the epidemiology of Acanthamoeba keratitis, Ophthalmic Epidemiol, vol.14, pp.53-60, 2007.

R. T. Cursons, T. J. Brown, E. A. Keys, K. M. Moriarty, and D. Till, Immunity to pathogenic free-living amoebae: role of humoral antibody, Infect Immun, vol.29, pp.401-408, 1980.

N. Brindley, A. Matin, and N. A. Khan, Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations, Expe Parasitol, vol.121, pp.254-260, 2009.

D. W. Clarke, The pathophysiology of Acanthamoeba keratitis, Trends in Parasitology, vol.22, pp.175-180, 2006.

H. Alizadeh, Roleofcontactlenswear,bacterialflora,and mannose-induced pathogenic protease in the pathogenesis of amoebic keratitis, Infect. Immun, vol.73, pp.1061-1068, 2005.

D. W. Clarke, Failure of Acanthamoeba castellanii to produce intraocular infections, Invest. Ophthalmol. Vis. Sci, vol.46, pp.2472-2478, 2005.

H. Alizadeh, Role of activated macrophages in Acanthamoeba keratitis, Journal of Parasitology, vol.93, pp.1114-1120, 2007.

N. A. Khan, Pathogenesis of Acanthamoeba infections, Microb Pathog, vol.34, p.277, 2003.

S. Watson, J. Dart, G. J. Johnson, D. Minassian, R. A. Weale et al., Acanthamoeba keratitis, The epidemiology of eye disease, pp.200-205, 2003.

M. J. Bharathi, R. Ramakrishnan, R. Meenakshi, S. Padmavathy, and C. Shi-vakumar,

M. Srinivasan, Microbial keratitis in South India: influence of risk factors, climate, and geographical variation, Ophthalmic Epidemiol, vol.14, pp.61-70, 2007.

N. R. Acharya, T. M. Lietman, and T. P. Margolis, Parasites on the rise: a new epidemic of Acanthamoeba keratitis, Am J Ophthalmol, vol.144, pp.292-295, 2007.

C. D. Illingworth and S. D. Cook, Acanthamoeba keratitis, Surv Oph-thalmol, vol.42, pp.493-508, 1998.

J. K. Stehr-green, T. M. Bailey, and G. S. Visvesvara, The epidemiology of Acanthamoeba keratitis in the United States, Am J Ophthalmol, vol.107, pp.331-337, 1989.

S. Sharma, P. Garg, and G. N. Rao, Patient characteristics, diagnosis, and treatment of noncontact lens related Acanthamoeba kera-titis, Br J Ophthalmol, vol.84, pp.1103-1111, 2000.

E. Houang, D. Lam, D. Fan, and D. Seal, Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection, Trans R Soc Trop Med Hyg, vol.95, pp.361-368, 2001.

M. J. Bharathi, R. Ramakrishnan, R. Meenakshi, S. Padmavathy, and C. Shi-vakumar,

M. Srinivasan, Microbial keratitis in South India: influence of risk factors, climate, and geographical variation, Ophthalmic Epidemiol, vol.14, pp.61-70, 2007.

S. Kilvington, T. Gray, J. Dart, N. Morlet, J. R. Beeching et al.,

, Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom, Invest Ophthalmol Vis Sci, vol.45, pp.165-174, 2004.

W. D. Mathers, J. E. Sutphin, J. A. Lane, and R. Folberg, Correlation bet-ween surface water contamination with amoeba and the onset of symptoms and diagnosis of amoeba-like keratitis, Br J Oph-thalmol, 1998.

C. F. Radford, O. J. Lehmann, and J. K. Dart, Acanthamoeba kera-titis: multicentre survey in England 1992-1996. National Acanthamoeba Keratitis Study Group, Br J Ophthalmol, vol.82, pp.1387-92, 1998.

T. K. Butler, J. J. Males, L. P. Robinson, A. W. Wechsler, G. L. Sutton et al., Sixyear review of Acanthamoeba keratitis in New South Wales Australia, Clin Experiment Oph-thalmol, vol.33, pp.41-47, 1997.

A. C. Fears, Comparative in vitro effectiveness of a novel contact lens multipurpose solution on Acanthamoeba castellanii, Journal of ophthalmic inflammation and infection, vol.8, 0119.

C. F. Radford, D. C. Minassian, and J. K. Dart, Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors, Br J Ophthalmol, vol.86, pp.536-578, 2002.

C. E. Joslin, E. Y. Tu, M. E. Shoff, G. C. Booton, P. A. Fuerst et al., The association of contact lens solution use and Acan-thamoeba keratitis, Am J Ophthalmol, vol.144, pp.169-80, 2007.

C. E. Joslin, E. Y. Tu, T. T. Mcmahon, D. J. Passaro, L. T. Stayner et al., Epidemiological characteristics of a Chicago-area Acantha-moeba keratitis outbreak, Am J Ophthalmol, vol.142, pp.212-219, 2006.

H. J. Jeong, S. J. Lee, J. H. Kim, Y. H. Xuan, K. H. Lee et al., Acanthamoeba: keratopathogenicity of isolates from domestic tap water in Korea, Exp Parasitol, vol.117, pp.357-67, 2007.

I. Claerhout, A. Goegebuer, B. C. Van-den, and P. Kestelyn, Delay in diag-nosis and outcome of Acanthamoeba keratitis, Graefes Arch Clin Exp Ophthalmol, vol.242, pp.648-53, 2004.

A. S. Bacon, J. K. Dart, L. A. Ficker, M. M. Matheson, and P. Wright, Acantha-moeba keratitis The value of early diagnosis, Ophthalmology, vol.100, pp.1238-1281, 1993.

D. W. Clarke and J. Y. Niederkorn, The immunobiology of Acanthamoeba keratitis, Microbes Infect, vol.8, pp.1400-1405, 2006.

Z. Sunx, . Lir, . Wangz, . Luos, and . Gaom, Acanthamoeba keratitis: clinical characteristics and management, Ophthalmology, vol.113, pp.412-418, 2006.

A. S. Bacon, D. G. Frazer, J. K. Dart, M. Matheson, L. A. Ficker et al., A review of 72 consecutive cases of Acanthamoeba keratitis, Eye, vol.7, pp.719-744, 1984.

E. Y. Tu, C. E. Joslin, J. Sugar, M. E. Shoff, and G. C. Booton, Prognostic factors affecting visual outcome in Acanthamoeba keratitis, Ophthalmology, vol.115, pp.1998-2003, 2008.

J. K. Dart, V. P. Saw, and S. Kilvington, Acanthamoeba keratitis: diagnosis and treatment update, Am J Ophthalmol, vol.148, pp.487-99, 2009.

S. Murthy, N. R. Hawksworth, and I. Cree, Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate, Cornea, vol.21, pp.237-246, 2002.

N. L. Herz, A. Y. Matoba, and K. R. Wilhelmus, Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis, Ophthalmology, vol.115, pp.866-875, 2008.

X. Zhang, X. Sun, C. Jiang, Z. Wang, Y. Zhang et al., A new in vivo confocal microscopy prognostic factor in Acanthamoeba keratitis, J Fr Ophtalmol, vol.37, pp.130-137, 2014.

W. D. Mathers, S. E. Nelson, J. L. Lane, M. E. Wilson, R. C. Allen et al., Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis, Arch Ophthalmol, vol.118, pp.178-83, 2000.

O. J. Lehmann, S. M. Green, N. Morlet, S. Kilvington, M. F. Keys et al.,

, Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis, Invest Ophthalmol Vis Sci, vol.39, pp.1261-1266, 1998.

Y. Ikeda, D. Miyazaki, K. Yakura, A. Kawaguchi, R. Ishikura et al.,

D. F. Larkin, S. Kilvington, and J. K. Dart, Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide, Ophthalmology

J. Hay, C. M. Kirkness, D. V. Seal, and P. Wright, Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy, Eye, vol.8, pp.555-63, 1994.

S. Kilvington, R. Hughes, J. Byas, and J. Dart, Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates, Antimicrob Agents Chemother, vol.46, pp.2007-2016, 2002.

D. Perrine, J. P. Chenu, P. Georges, J. C. Lancelot, C. Saturnino et al., Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga

, Antimicrob Agents Che-mother, vol.39, pp.339-381, 1995.

M. Kandori, T. Inoue, M. Shimabukuro, H. Hayashi, Y. Hori et al., Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy, Cornea, vol.29, pp.1199-202, 2010.

Y. M. Por, J. S. Mehta, J. L. Chua, T. H. Koh, W. B. Khor et al., Acanthamoeba keratitis associated with contact lens wear in Singapore, Am J Ophthalmol, vol.148, pp.7-12, 2009.

L. Gardun-Õ-vieyra, C. R. Gonzalez-sanchez, H. Mota, and S. E. , Ultraviolet-a light and riboflavin therapy for Acantha-moeba keratitis: a case report, Case Rep Ophthalmol, vol.2, pp.291-296, 2011.

. Hernández-martínez, Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico, 2019.

, Experimental Parasitology

A. J. Carrillo-muñoz, G. Giusiano, P. A. Ezkurra, and G. Quindós, Antifungal agents : Mode of action in yeast cells, Rev Esp Quimioterap, 2006.

!. Vidal and . Le-dictionnaire, Edition du Vidal, quatre-vingt-quinzième édition, 2019.

. David-r-haburchak, Acanthamoeba Infection Treatment & Management Updated, 2017.

S. Bang, E. Edell, A. O. Eghrari, and J. D. Gottsch, Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis, Am J Ophthalmol, vol.149, pp.66-75, 2010.

E. Y. Tu, C. E. Joslin, and M. E. Shoff, Successful treatment of chronic stromal Acanthamoeba keratitis with oral voriconazole mono-therapy, Cornea, vol.29, pp.1066-1074, 2010.

A. Cabello-vílchez, C. &. Martín-&-martín-navarro, and . López-arencibia,

. Atteneri-&-reyes-batlle, &. María, I. &. Sifaoui, . Valladares, &. Basilio et al., Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru, 2013.

K. Sunadaa and N. , In vitro evaluations of topical agents to treat Acanthamoeba keratitis, Ophthalmology, vol.121, pp.2059-65, 2014.

C. M. Martin-navarro, A. Lopez-arencibia, and F. Arnalich-montiel, Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba, Graefes Arch Clin Exp Ophthalmol, vol.251, pp.2111-2118, 2013.

A. Lovieno, D. Miller, and D. R. Ledee, Cysticidal activity of antifungals against different genotypes of Acanthamoeba, Antimicrob Agents Chemother, vol.58, pp.5626-5634, 2014.

, J Ophthalmic Inflamm Infect, vol.8, issue.1, p.19, 2018.

, Eye Contact Lens, vol.45, issue.3, pp.164-170, 2019.

, Contact Lens Anterior Eye, 2018.

. Hildebrandt-c, . Wagner-d, T. Kohlmann, and . Kramer-a, In-vitro analysis of the microbiocidal activity of 6 contact lens care solutions, BMC Infect Dis, vol.12, issue.2, 2012.

. Serment-de-galien,

, Je jure d'honorer ceux qui m'ont instruit dans les préceptes de mon art et de leur témoigner ma reconnaissance en restant fidèle à leur enseignement

D. , intérêt de la Santé publique ma profession avec conscience et de respecter non seulement la législation en vigueur mais aussi les règles de l'Honneur

, De ne jamais oublier ma responsabilité et mes devoirs envers le malade et sa dignité humaine

, De ne dévoiler à personne les secrets qui m'auraient été confiés ou dont j'aurais eu connaissance dans l'exercice de ma Profession

, En aucun cas, je ne consentirai à utiliser mes connaissances et mon état pour corrompre les moeurs et favoriser les actes criminels

, Que les hommes m'accordent leur estime si je suis fidèle à mes promesses. Que je sois méprisé de mes Confrères si je manque à mes engagements

!. %&-;-*"+, +. #&, and .. /. , 0)1.'%&2#/&$%2&+2

!. %&#, , p.9

, La kératite amibienne est une pathologie rare et sous-diagnostiquée. La récente croissance d'utilisation des lentilles de contact entraine une augmentation de son incidence, par manque de prévention et de produits d

, Un retard de prise en charge entraîne des lésions cornéennes importantes et irréversibles allant jusqu'à la cécité. Le traitement de cette pathologie n'est à ce jour pas clairement défini du fait de l'émergence de nouvelles molécules utilisées dans cette indication, Bien que rare, la kératite amibienne n'en reste pas moins une pathologie grave et nécessite un diagnostic précoce

, Après avoir réalisé une mise en contact d'un inoculum calibré du parasite à différentes concentrations de voriconazole, des dénombrements ont été réalisés à plusieurs intervalles de temps, ce qui a permis de déterminer les CI50 de chaque espèce

A. , A. Castellanii, A. Lenticulata-;-!-ssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssssss!-&gt;?@&lt;&amp;abc&lt;&amp;t!up1-;-!v!l*(-;-!v!!&quot;#$%&amp;#-;-#*+, and -. +&amp;#/#!v!!&quot;#$%&amp;#, Ces deux dernières espèces ont une sensibilité quasiment similaire au voriconazole, 15*.)(<.'2!VV!W)@2*:5.)! :2''B15XB2

^. Ajn, >B2! Y/2!Y^88W[!I2115)2+!Q.*:2B1!2)!IN